WG
KYNB

Winton Group’s Kyntra Bio KYNB Stock Holding History

Winton Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-463
Closed -$118K – 1136
2021
Q3 		$118K Sell
463
-103
-18% -$36.5K 0.01% 1284
2021
Q2 		$377K Sell
566
-132
-19% -$76K 0.02% 1067
2021
Q1 		$606K Buy
698
+2
+0.3% +$2.13K 0.03% 770
2020
Q4 		$646K Sell
696
-574
-45% -$603K 0.05% 655
2020
Q3 		$1.31M Sell
1,270
-402
-24% -$433K 0.04% 696
2020
Q2 		$1.7M Sell
1,672
-943
-36% -$876K 0.04% 726
2020
Q1 		$2.27M Sell
2,615
-56
-2% -$55.7K 0.06% 534
2019
Q4 		$2.86M Buy
+2,671
New +$2.73M 0.04% 672
2019
Q2 		– Sell
-160
Closed -$218K – 1180
2019
Q1 		$218K Buy
+160
New +$217K ﹤0.01% 935
2018
Q4 		– Sell
-205
Closed -$311K – 924
2018
Q3 		$311K Buy
205
+5
+3% +$7.7K 0.01% 804
2018
Q2 		$313K Sell
200
-144
-42% -$188K 0.01% 812
2018
Q1 		$397K Buy
+344
New +$453K 0.01% 872

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Winton Group's KYNB Position: Q4 2021 in Review

Winton Group sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 463 shares — an estimated $118K sold.

Winton Group first reported a position in KYNB in Q1 2018 and held it in 12 quarters. The position peaked at $2.86M in Q4 2019. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • Winton Group reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 463 Kyntra Bio shares in Q4 2021, an estimated $118K.
  • Winton Group first reported a position in Kyntra Bio in Q1 2018 and held it in 12 quarters.
  • Winton Group's Kyntra Bio position peaked at $2.86M in Q4 2019.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.